News - Keryx Biopharmaceuticals, Mercury Pharma


Popular Filters

US nephrologists views on prescribing Roche’s Mircera


Among surveyed US nephrologists, familiarity with Swiss drug major Roche's Mircera is low, but is still…

InjectaferKeryx BiopharmaceuticalsMirceraNeurologicalNorth AmericaPharmaceuticalRocheZerenex

Keryx Biopharma files for US approval of Zerenex


Keryx Biopharmaceuticals (Nasdaq: KERX) says it has submitted a New Drug Application to the US Food and…

BiotechnologyKeryx BiopharmaceuticalsNephrology and HepatologyNorth AmericaRegulationZerenex

Amdipharm and Mercury Pharma merge


As has been expected, Amdipharm and Mercury Pharma - both subsidiaries of Channel Islands-based private…

Amdipharm Mercury CompanyGenericsMercury PharmaMergers & Acquisitions

Keryx Biopharma rockets on new Zerenex data and plans to file for approval


USA-based Keryx Biopharmaceuticals (Nasdaq: KERX) saw its shares close up a whopping 77% to $4.70 in…

BiotechnologyKeryx BiopharmaceuticalsNephrology and HepatologyPharmaceuticalRegulationRenagelRenvelaResearchSanofiZerenex

Cinven snaps up Amdipharm for £367 million


Channel Islands-based private equity firm Cinven has reached agreement to acquire UK-based niche generic…

AmdipharmCinvenGenericsMercury PharmaMergers & Acquisitions

Cinven to acquire Mercury Pharma for $730 million


Cinven, a Channel Islands-based private equity firm, said last Friday that it has reached agreement to…

CinvenGenericsMercury PharmaMergers & AcquisitionsPharmaceutical

News briefs: Roche's dalcetrapib; Coherus/Daiichi deal; Mercury Pharma; AEterna Zentaris


Swiss drug major Roche (ROG: SIX) saw its shares drop 4.5% to 159.30 Swiss francs by around midday yesterday,…

AEterna ZentarisBiotechnologyCoherus BioSciencesDaiichi SankyodalcetrapibGenericsKeryx BiopharmaceuticalsLicensingMercury PharmaMergers & AcquisitionsperifosinePharmaceuticalResearchRoche

AEterna Zentaris and Keryx shares tank as cancer drug flops in Ph III


Canadian drug developer AEterna Zentaris (TSX: AEZ) and US licensee Keryx Pharmaceutical (Nasdaq: KERX)…

AEterna ZentarisKeryx BiopharmaceuticalsLicensingNephrology and HepatologyOncologyperifosinePharmaceuticalResearchZerenex

Goldshield and affiliates rebrand as Mercury Pharma


Goldshield, an international speciality pharmaceutical company selling niche generic prescription and…

GenericsGoldshieldMarkets & MarketingMercury Pharma

Back to top